InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: None

Thursday, 03/25/2021 9:31:13 AM

Thursday, March 25, 2021 9:31:13 AM

Post# of 17454
ICER evidence presentation re Lupkynis vs. Benlysta due tomorrow. It will be interesting to see if the final report (April) will still say Lupkynis is more cost effective than Benlysta

https://icer.org/assessment/lupus-nephritis-2021/#timeline
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News